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Abstract.
Background:Freezing of gait (FOG) is a mysterious, complex and debilitating phenomenon in Parkinson’s disease. Adequate
assessment is a pre-requisite for managing FOG, as well as for assigning participants in FOG research. The episodic nature
of FOG, as well as its multiple clinical expressions make its assessment challenging.
Objective: To highlight the available assessment tools and to provide practical, experience-based recommendations for
reliable assessment of FOG.
Methods: We reviewed FOG assessment from history taking, questionnaires, lab and home-based measurements and exam-
ined how these methods account for presence and severity of FOG, their limits and advantages. The practicalities for their
use in clinical and research practice are highlighted.
Results: According to the available assessment tools severity of FOG is marked by one or a combination of multiple clinical
expressions including frequency, duration, triggering circumstances, response to levodopa, association with falls and fear of
falling, or need for assistance to avoid falls.
Conclusions: To date, a unique methodological tool that encompasses the entire complexity of FOG is lacking. Combining
methods should give a better picture of FOG severity, in accordance with the precise clinical or research context. Further
development of any future assessment tool requires understanding and thorough analysis of the specific clinical expressions
of FOG.
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INTRODUCTION
Freezing is commonly observed in Parkinson’s dis-
ease and Parkinsonism and may affect leg, hand and
speech movements [1]. Here, we focus on freezing of
gait (FOG). FOG is an episodic absence or marked
reduction of forward progression of the feet despite
the intention to walk [2]. Although this definition is
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very functional, it does not reflect the multiple clinical
and physiological expressions of the phenomenon.
FOG can be very “troublesome” and is often respon-
sible for falls [3]. Successful assessment of FOG is
a pre-requisite for managing the symptom as well as
for assigning participants in FOG research [4].
THE CHALLENGE OF ASSESSING FOG
There are multiple reasons why FOG assessment
is challenging. Because it is an episodic phenomenon
[4], its observation may require the use of trigger-
ing tricks, such as increased cognitive load, as in
dual tasking, or stressful situations, such as react-
ing under time pressure [5]; in addition, FOG may
disappear during the examination due to the patient
paying extra attention to gait [4]. Indeed, cognitive
[6] and affective factors [7] contribute to the episodic
nature of FOG. Therefore, FOG assessment should
start as soon as the patient stands up from the waiting
room chair because it may be the single opportu-
nity to observe it before attentional mechanisms start
to suppress it. This episodic nature may hinder the
assessment of FOG by objective methods lending
weight to the use of subjective assessment tools [2, 8].
The reliability of such subjective methods hinges on
the awareness of FOG among the patients and care-
givers. Objective home and lab-based methods are
necessary to enquire further about FOG as it varies
in its onset in the course of the disease [9]; response
to levodopa [9, 10], clinical manifestation [2, 11],
triggering circumstances (start hesitation, turn and
destination FOG, shuffling forward with short steps)
[4], relation to cognitive dysfunction [5], and asso-
ciation with postural instability and falls [12, 13].
Festination is defined as the tendency to move for-
ward with increasingly rapid, but ever smaller steps
and is frequently present in patients with FOG. How-
ever, because it does not systematically precede FOG,
as in start hesitation, we consider it as a separate, gait
disturbance [2]. A decision tree can help to pin down
freezer/non-freezer classification by identifying 3
categories: (1) “self-reported freezer”, when freezing
is only attested by self-report; (2) “probable freezer”,
when presence of FOG is confirmed by a third person
(caregiver); and (3) “definite freezer”, when freezing
is actually observed during formal objective testing
by an experienced professional [14]. Further evalua-
tion using home or lab-based quantitative testing has
been suggested to confirm the presence of FOG in
self-reported and probable freezers.
In practice, the FOG assessment(s) chosen depends
on the context, with subjective methods used mostly
in routine clinical setting, and objective methods,
especially needed in research settings or when treat-
ment adjustment is needed. However, a combination
of both may provide a fuller picture. Here we review
the assessment tools for FOG, distinguishing between
subjective, clinical and objective tools. We high-
light their advantages and limitations within clinical
and research settings and offer an experience-based
account. We place special emphasis on each assess-
ment tool’s ability to mark FOG severity as the
severity of FOG impacts changes in medication or
Deep Brain Stimulation (DBS) settings, as well as
therapy (for example physiotherapy, occupational
therapy).
SUBJECTIVE METHODS
History-taking
This interview allows for the clarification of the
meaning of FOG with the patient, and is the start
of the inquiry into how troublesome FOG is for the
purpose of managing the symptom [3]. Rather than
referring to ‘freezing’ a patient can be asked about
the typical experience of feeling as if their feet were
glued to the floor, or about being suddenly unable
to move forward [3]. It is also helpful to demon-
strate what freezing actually looks like, both to the
patient and caregiver by e.g. showing patients a video
of examples of variants of FOG, as is done in the
New Freezing of Gait Questionnaire (NFOGQ) [15].
Videos describing FOG from a patient’s point of view
can make it less daunting for a patient to identify their
symptoms [16].
Incorporating the NFOGQ at this point is use-
ful to probe the severity of FOG. Asking about
the effect of medication is necessary to sepa-
rate out levodopa-responsive vs. levodopa-resistant
FOG. In addition, as FOG constitutes a major risk
factor for falls in Parkinson patients, it is recom-
mended to ask for past falls or about the fear of
falling.
Questionnaire-based assessment methods
Questionnaires provide a global overview of FOG
that complements other measures in the clinic, and
for research purposes such as when a follow-up by
phone is required.
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The unified Parkinson’s disease rating scale [17]
or the Movement Disorder Society-UPDRS (UPDRS
Part II, item 14, and MDS-UPDRS Part II, item
2.13: Activities of Daily Living) [18] offers the
opportunity to ask the patient about the presence
and severity of FOG both OFF and ON medica-
tion. This is needed if it is not possible for the
examiner to perform a levodopa challenge. Knowing
if the patient has dopamine-responsive, dopamine-
resistant or dopamine-induced FOG is critical for
further management [3]. Compared with the former
UPDRS, the MDS-UPDRS measures fall risk instead
of actual falls. The UPDRS questionnaires only allow
the examiner to get some insight into the presence
and burden of FOG in daily life, and not to finely
characterize its features.
Apart from the FOG items from the MDS-UPDRS,
two validated questionnaires exist: the original Freez-
ing of Gait Questionnaire (FOGQ) [19] and the
NFOGQ [15]. The NFOGQ is very useful as it mea-
sures the severity of FOG in terms of frequency of
occurrence, intensity and duration of the longest FOG
episodes, and subjective impact on quality of life and
activities of daily living. However, the questions only
stress gait initiation and turning, which are the most
common triggers of FOG [10], but not the only ones,
and no distinction is made between FOG in the ON
and/or OFF states. The Gait and falls questionnaire
(GFQ) includes questions relating to gait in general
and falls, and is therefore not deemed specific enough
for FOG assessment [20]. However, compared to the
NFOGQ, it covers a larger range of FOG trigger-
ing circumstances and questions patients both about
the longest and a typical FOG episode, which might
be more sensitive to detect changes associated with
therapeutic adjustments. On their own questionnaires
seldom suffice; even more so as the questionnaire out-
come and objective measures might not necessarily
correlate [21].
Home-based assessment methods
Given that FOG is most commonly experienced at
home [22], assessing FOG in a person’s home envi-
ronment carries a lot of merit. It provides ecological
information on FOG occurrence in daily life. In addi-
tion, it enables the recording of fluctuations of FOG
during the day, a feature that cannot be grasped during
a patient’s visit or during laboratory measurement.
Diaries, paper or online ones, are a cost-effective
way to assess FOG that can yield information on
the burden of the symptom in the patient’s daily life
[3]. Once FOG behavior to be recorded has been
described to the patient and caregiver [23], a care-
fully structured diary may gather the frequency of
FOG episodes, time of day, triggering circumstances
(such as walking through a doorway), and whether
the episode resulted in a fall or a near-fall. This
information can allow pharmacological treatment and
Deep Brain Stimulation settings to be adjusted [24],
help define specific physiotherapy and occupational
therapy goals, and inform on the efficacy of an inter-
vention. Asking the patient to keep a diary would
enable the adjustment of DBS settings and provide
information on the time course of the effect. The
drawback of a diary is that reports lie in the hands
of patients even more than for questionnaires. The
diary can only be kept by patients without cognitive
issues, and, depending on the purpose and duration
over which it needs to be filled, it requires follow-
up by a researcher or therapist every week to ensure
correct completion [25, 26]. Even then, it can prove
impossible to record all FOG episodes, especially in
patients with severe FOG. Given these limitations
diaries should be combined with other assessment
methods. In this way they can yield useful informa-
tion on the burden of the symptom in the patient’s
daily life [3].
CLINICAL EXAMINATION
Clinical examination aims at objectively verifying
the presence of FOG and assessing severity, respon-
siveness to treatment, and triggering circumstances,
in an environment where time is precious.
The MDS-UPDRS III FOG item allows for the
clinical recording of the severity of the symptom
based on its precipitating circumstances [18]. It
assesses the severity of FOG on a 0 to 4 scale, with
FOG during straight walking considered to be more
severe than FOG occurring during turning, starting
or walking in a narrow space. However, as FOG is
assessed through a single item that may miss out pos-
sible FOG triggering circumstances it is not sensitive
enough. In addition, it does not take the duration of
the episodes into account.
Ziegler et al. proposed a clinical rating instru-
ment for FOG and festination [27], termed the FOG
score. This FOG score measures the occurrence of
FOG in a trajectory comprising four possible trig-
gering circumstances (start hesitation, clockwise and
counter clockwise turns, narrow space), combined
or not with a dual task. Its originality comes from
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the discrimination between the different FOG clini-
cal patterns, with festination or shuffling considered
less severe than FOG associated with leg trembling or
akinetic FOG, which in turn is less severe than FOG
causing abortion of task or need for external help
and/or cue. This FOG score is a cost-effective instru-
ment for detailed examination of FOG but takes up to
15 minutes to administer. Also, it does not incorporate
all possible FOG triggers in the computation of FOG
severity, especially when these could further inform
on FOG severity, with FOG occurring while walk-
ing straight being the most severe form. Weighting
the different triggering circumstances by recording
their frequency [28] would augment the instrument’s
utility. Finally, the FOG score does not consider the
duration of FOG episodes even though, beyond the
simple occurrence of FOG itself, FOG duration is a
major indicator of FOG severity.
Because of the lack of a satisfyingly compre-
hensive clinical scoring tool, a number of authors
have used so-called “FOG trajectories” to objectify
FOG during clinical examination [4, 10, 14, 24, 29,
30]. Examination of freezing typically includes 360
degree rapid turns, small steps walking, stops on
command, narrow or cluttered passages, dual motor-
tasking such as carrying a tray, and cognitive dual
tasking. Caution should however be exercised as such
maneuvers may lead to falls. It is recommended to
stand close to the patients, especially when asking
them to perform the rapid short steps test, as they
tend to walk very fast and fall over. Using a safety
harness, usually available in a lab, during rapid,
full turns can allow FOG to be detected with less
turns, as the person being tested is more likely to
turn more rapidly, than they would if the test were
being conducted in a normal examination room. Step-
ping in place and backward walking may also trigger
FOG in some patients [31, 32]. Such clinical assess-
ment can be adapted to each patient individually. If
the aim is simply to detect FOG, then assessment
can stop as soon as the symptom is observed. Con-
versely, in a patient with self-reported FOG who
does not immediately demonstrate FOG during clin-
ical examination, it is useful to combine several
triggering circumstances. Increasing the cognitive
load will prevent patients from relying on atten-
tional processes to control gait, and this may help to
unveil FOG.
Sometimes, even such complex and distracting
tasks will not trigger FOG during the clinical eval-
uation in a known freezer. In such cases, assessment
should be repeated at another visit, and possibly in a
practically defined OFF state (to minimize a masking
effect by dopaminergic medication).
OBJECTIVE METHODS
Lab-based assessment methods
For research into specific effects on FOG a lab
assessment is necessary. In the lab, a clinical test
battery can be supplemented with gait protocols.
The FOG event(s) can be captured on video [24,
33] for off-line, blinded, experienced rating which is
the current gold standard for assessing the severity
of FOG [34]. Video recording may be synchro-
nized with assessment technology, including motion
capture systems, inertial sensors [35] or pressure sen-
sitive insoles and mats to capture very short FOG
episodes which may be missed by the naked clini-
cal eye [36], as well as abnormal gait parameters just
prior or in between an episode.
An advantage of assessing FOG in a lab environ-
ment is the ability to assess and compare a patient in
both a well-defined ON (using a supramaximal lev-
odopa dose), and OFF state (overnight withdrawal of
dopaminergic medication) [37]. In the case of OFF
state freezers (which is the most common subtype),
especially during the early stages of PD [2, 10], FOG
can be difficult to elicit in a standard clinical setting as
patients usually take their medication before the visit
[4]. Being able to test a patient in the OFF state both
increases the likelihood of detecting FOG and enables
one to document the effect of medication, as well as
its time course during the levodopa challenge. How-
ever, lab testing remains limited in informing on FOG
severity as it is too short an assessment to capture
FOG longitudinally. For this reason it is important to
supplement lab data with a questionnaire such as the
NFOGQ or a home-based assessment.
Home-based assessment methods
Wearable technology containing inertial sensors
holds promise for a more objective assessment of
FOG. The recording of gait abnormalities in between
or prior to FOG episodes [38] provide a fuller picture
of the FOG events allowing more accurate assess-
ment of therapeutic strategies [39]. To our knowledge
this wearable technology is still only used in research
settings and clinical application will depend on fur-
ther development of automated feature learning for
the detection of FOG episodes. This challenge arises
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Table 1
Markers of severity of FOG: existing assessment tools, uses and main drawbacks
Tool/method Markers of FOG severity Use Main drawback
Subjective UPDRS II, item 14 Falls frequency Neurological examination Relies on patient ability to
Response to medication Lab-based research study report on FOG
MDS-UPDRS II, item 2.13 Need for assistance
History taking FOG presence/absence
How troublesome FOG is
Response to medication
NFOGQ FOG frequency
FOG duration
Need for assistance
Fear of falling
FOG impact on daily living
FOGQ FOG duration
Need for assistance
FOG impact on daily living
(very brief)
Diaries FOG frequency Home based intervention
study
Relies on patient compliance
FOG duration
Follow-up of patientFOG triggering
circumstances
Time of day FOG occurs
Occurrence relative to
medication
Number of FOG-related falls
Objective MDS-UPDRS III, item 3.11 FOG presence Neurological examination Captures only a “moment in
FOG frequency Lab-based research study time”
FOG triggering
circumstances
Lab-measurement/video FOG frequency
FOG duration
FOG triggering
circumstances
Number of near-falls/falls
Response to medication
Gait parameters
FOG score FOG presence
FOG triggering
circumstances
Sensors FOG frequency Home based intervention
study
Requires further development
to reliably pick up all FOG
clinical patterns
FOG duration
Lab-based research study
(except for ‘Time of day
FOG occurs’)
Time of day FOG occurs
Follow-up of patient
Gait parameters
UPDRS, Unified Parkinson’s disease rating scale [17]; MDS-UPDRS, Movement Disorder Society-UPDRS [18]; NFOGQ, New Freezing
of Gait Questionnaire [15]; FOGQ, Freezing of Gait Questionnaire [19]; FOG score, Freezing of Gait-Score [27].
because of the different clinical patterns of FOG
[11]. The most common form involves leg trembling
with no effective forward motion (the trembling-in-
place pattern). FOG detection algorithms capturing
this 3–8 Hz oscillation pattern of the legs [40] yield
the best results when the inertial sensor is placed on
the shank, above the ankle joint [41, 42], especially,
from our experience, on the leg that is hesitant dur-
ing movement initiation. The sensitivity for an IMU
placed at the shank is high though the specificity
is rather low [41]. Additionally there is good cor-
relation for the number of episodes (ICC 0.78) and
very strong correlation for percent time frozen (ICC
0.93) between the accelerometry derived method for
detecting 3–8 Hz oscillation pattern of the legs and
the clinical offline video rating [43]. Alternatively
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a triaxial accelerometer worn at the waist when
employing a linear support vector machine analy-
sis approach can yield very high accuracy (98.7%)
in detecting FOG [44]. However, the accuracy may
decrease when the method is used in an unconstrained
home environment. Furthermore, this state-of-the-art
method has only been tested on very small population
samples.
In some patients, FOG is associated with festina-
tion [45] in which short, shuffling steps are observed
but forward movement is minimal. Recently, an algo-
rithm evaluating cadence and stride length data from
an IMU placed on the shank has been developed to
detect this ‘festinating’ type of FOG [39]. FOG can
also manifest as complete akinesia, where no motion
of the legs is observed and patients describe an interim
period where they passively wait for the spontaneous
resolution of the FOG episode. This last clinical pat-
tern of FOG is a challenge for detection algorithms as
it can be confused with simple stance [46]. A more in
depth review of available algorithms to detect FOG
has recently been published [47].
Home-based assessments are not an option when
the effect of adjunct/germinal therapies for FOG last
a short while. Such is the case for repetitive tran-
scranial magnetic stimulation (rTMS) [48], where the
assessment of FOG should be done at most within
one hour following the stimulation protocol [49].
Particularly in such cases, lab-based assessments are
necessary.
TAKE HOME MESSAGE
Careful assessment of FOG is a pre-requisite
for fine-tuning the management strategy. From a
researcher’s point of view, properly stratifying into
freezers and non-freezers but also into different FOG
subtypes appears important for further understanding
of the phenomenon. To date, a unique methodological
tool that encompasses the entire complexity of FOG
is lacking and the best marker of severity is unclear:
patient’s self-evaluation of FOG severity, clinical pat-
tern, triggering circumstances, FOG frequency, FOG
duration, response to levodopa or need for assis-
tance to avoid falls (Table 1). Further development
of such an assessment tool requires understanding
and thorough analysis of the specific FOG character-
istics. As it stands, to reliably assess FOG severity, a
combination of FOG assessment tools is necessary,
in accordance with the clinical or specific research
context of the assessment need.
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